arrow
C

Christian Drosten

charite-universitaetsmedizin berlin
H指数:136
被引数:13.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A case of Bundibugyo virus disease treated with monoclonal antibodies and remdesivir

使用单克隆抗体和瑞德西韦治疗的布桑加里病毒病病例

2026-08-240
OA
Post-Exposure Prophylaxis with a monoclonal antibody cocktail Following Bundibugyo Ebolavirus Exposure in Adults and Children

在 Bundibugyo 埃博拉病毒暴露后,成人和儿童使用单克隆抗体鸡尾酒进行暴露后预防

2026-08-240
OAAI
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults

健康成人接种MVA-MERS-S疫苗后,MERS-CoV特异性抗体和T细胞应答的两年持续性

2026-01-090
OAAI
Initiation of a coronavirus vaccine library

冠状病毒疫苗库的建立

Vaccine
IF3.5
2025-12-200
PRE
Improving epidemiological projections for infectious diseases in Ghana: addressing methodological challenges

改进加纳传染病流行病学预测:解决方法学挑战

2025-09-220
OAAI
A systematic nomenclature for mpox viruses causing outbreaks with sustained human-to-human transmission

引起持续人传人暴发的mpox病毒的系统命名

2025-07-290
PRE
From crisis to routine – Standardization of SARS-CoV-2 genome detection by enhanced EQA schemes in a scientific pandemic network

从危机到常规——通过科学大流行网络中的增强EQA方案标准化SARS-CoV-2基因组检测

2025-05-240
OA
SARS-CoV-2 Infection of Human Lung Air-Liquid Interface Cultures Reveals Basal Cells as Relevant Targets

SARS-CoV-2感染人肺气-液界面培养物揭示了基底细胞为相关靶点

2025-03-110
PRE
Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trial

一种新型口服氯硝柳胺制剂的临床安全性及药代动力学研究,与市售氯硝柳胺咀嚼片在健康受试者中的比较:一项三部分随机、双盲、安慰剂对照试验

2025-02-250
OA
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

15个实验室SARS-CoV-2抗原性的全球协作比较

2024-12-180
OAAI